Tips from Other Journals

Brain Natriuretic Peptide Marks Cardiac Causes of Syncope



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2004 Sep 1;70(5):964-966.

Determining the causes of syncopal episodes can be difficult. Methods that would distinguish between cardiac, reflex-mediated, neurogenic, and idiopathic etiologies would be helpful. Brain natriuretic peptide plasma concentrations are being used widely to identify patients with myocardial dysfunction.

Tanimoto and associates measured brain natriuretic peptide levels on the morning after admission in 118 adult patients who were admitted to the hospital for syncope. The cause of syncope was determined using a diagnostic algorithm suggested by the American College of Physicians. Patients were classified into one of four etiologic categories; a majority (52 percent) had cardiac etiologies for the syncopal episode. The cause of syncope was unknown in 25 percent of the patients.

Brain natriuretic peptide was significantly higher in the cardiac group (118 ± 42 pg per mL) than in the other groups. The highest levels occurred in patients with organic cardiac disease, followed by those with tachycardia and then by those with bradycardia. Using a cutoff of 40 pg per mL, the sensitivity and specificity of brain natriuretic peptide levels in identifying cardiac syncope were 82 and 92 percent, respectively.

The authors conclude that cardiac causes for syncope are much more likely in patients with a brain natriuretic peptide level greater than 40 pg per mL. Electrocardiography and echocardiography are helpful in identifying specific cardiac causes. Because some patients in the unknown-cause group had elevated levels of brain natriuretic peptide, it is likely that these patients had cardiac syncope but that the specific cardiac disorder was not identified.

Tanimoto K, et al. Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. Am J Cardiol. January 15, 2004;93:228–30.


Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article